Abstract
Andrea De Filippis, Camillo Colli, Silvia Grillo, Ilenia Masi, Emanuela Jacchetti, Manuela Teresa Raimondi, Arianna Rossetti, Laura Rosanò, Davide Moscatelli, Emanuele Mauri
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Epidemiology and risk factors for ovarian cancer
2023
The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer
10.1002/hsr2.936 · 2022
Cancer statistics, 2020
2020
Deep learning framework for the prediction and diagnosis of ovarian cancer in Pre- and post-menopausal women
10.3390/diagnostics13101703 · 2023
Clinical symptoms of patients with early-stage and advanced-stage ovarian cancer
10.33371/ijoc.v18i3.1134 · 2024
Tumor microenvironment complexity: emerging roles in cancer therapy
10.1158/0008-5472.can-12-0122 · 2012
Research trends and hotspots in the tumor microenvironment of ovarian cancer: a bibliometrics and visualization study from 2005 to 2024
2025
Tumor-associated macrophages and platelets in tumor microenvironment and its potential therapeutic role in ovarian cancer
10.1007/s12094-025-03987-x · 2025
Front-line therapy of advanced epithelial ovarian cancer: Standard treatment
10.1093/annonc/mdx450 · 2017
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
2022
Nanomedicine disrupts stromal barriers to augment drug penetration for improved cancer therapy
10.1002/cjoc.202300642 · 2024
Drug delivery systems for overcoming physical barriers in cancer therapy
10.1021/acs.molpharmaceut.5c00474 · 2025
Nanotechnology in cancer drug delivery and selective targeting
10.1155/2014/939378 · 2014
Beyond matrix stiffness: targeting force-induced cancer drug resistance
10.1016/j.trecan.2023.07.006 · 2023
Integrin signaling in cancer cell survival and chemoresistance
10.1155/2012/283181 · 2012
The development of avastin
10.1007/978-3-540-33177-3_35 · 2008
Advances in targeted nano-delivery of Bevacizumab using nanoparticles: current insights, innovations, and future perspectives
2024
Mechanisms of chemotherapy resistance in ovarian cancer
2022
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance
10.1038/s41568-024-00723-5 · 2024
Biocompatible hydrogel Co-Delivering salvigenin and iridium (III) complex overcomes cancer stemness and cisplatin resistance in esophageal squamous cell carcinoma
2026
Cisplatin-loaded nanoformulations for cancer therapy: a comprehensive review
2022
Modulation of electrostatic interactions to improve controlled drug delivery from nanogels
10.1016/j.msec.2016.11.081 · 2017
Design and development of polymeric micelles with cleavable links for intracellular drug delivery
10.1016/j.progpolymsci.2012.07.002 · 2013
Synthesis of novel N-Vinylpyrrolidone/Acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells
10.1016/j.colsurfb.2019.110566 · 2020
All-in-One multifunctional tri-block glycopolymers for targeted delivery of cisplatin and cancer chemotherapy
2025
Smart stimuli-responsive nanogels: a potential tool for targeted drug delivery
10.2174/0113816128353985241231111149 · 2025
Nanogels as nanocarriers for drug delivery: a review
10.5599/admet.724 · 2019
Effects of primary amine-based coatings on microglia internalization of nanogels
10.1016/j.colsurfb.2019.110574 · 2020
Selective modulation of A1 astrocytes by drug-loaded nano-structured gel in spinal cord injury
10.1021/acsnano.9b05579 · 2020
Application of nanogels as drug delivery systems in multicellular spheroid tumor model
2022
Synthesis and biomedical applications of fluorescent nanogels
10.1039/c6py01021k · 2016
A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells
10.1038/s42003-022-03966-w · 2022
Folate-decorated nanogels for targeted therapy of ovarian cancer
10.1016/j.biomaterials.2011.04.006 · 2011
Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
10.1073/pnas.1805020115 · 2018
Novel insights into the role of discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention
10.1016/j.matbio.2023.12.003 · 2024
Prognostic significance of discoidin domain receptor 2 (DDR2) expression in ovarian cancer
2016
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
10.1158/1541-7786.mcr-23-0347 · 2023
Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix Metalloproteinase-2
10.1074/jbc.m107571200 · 2002
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
10.1016/j.bbcan.2023.189052 · 2024
Hyaluronic acid-polyethyleneimine nanogels for controlled drug delivery in cancer treatment
10.1021/acsanm.2c00524 · 2022
Novel Aurora A kinase inhibitor fangchinoline enhances Cisplatin–DNA adducts and cisplatin therapeutic efficacy in OVCAR‐3 ovarian cancer cells‐derived xenograft model
10.3390/ijms23031868 · doi-reference
Nanotechnology-based cisplatin intracellular delivery to enhance chemo-sensitivity of ovarian cancer
10.2147/ijn.s247114 · doi-reference
Dual-functionalized mesoporous silica nanoparticles for celecoxib delivery: amine grafting and imidazolyl PEI gatekeepers for enhanced loading and controlled release with reduced toxicity
10.3390/molecules29153546 · doi-reference
PH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents
10.1002/wnan.1389 · doi-reference
Responsive hydrogels of carboxymethyl cellulose and polyethyleneimine for efficient removal of ionic dye molecules
10.15376/biores.17.4.5785-5802 · doi-reference
Interaction and reactivity of cisplatin physisorbed on graphene oxide nano-prototypes
10.3390/nano10061074 · doi-reference
Cl–π interactions in protein–ligand complexes
10.1110/ps.033910.107 · doi-reference
Amino-aromatic interactions in proteins
10.1016/0014-5793(86)80730-x · doi-reference
pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect
10.1016/j.ijpharm.2015.10.066 · doi-reference
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation
10.1002/jps.21103 · doi-reference
Cisplatin-protein interactions: unexpected drug binding to N-Terminal amine and lysine side chains
10.1021/acs.inorgchem.6b01234 · doi-reference
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
10.1093/nsr/nwx062 · doi-reference
Acidic extracellular microenvironment and cancer
10.1186/1475-2867-13-89 · doi-reference
Acidity generated by the tumor microenvironment drives local invasion
10.1158/0008-5472.can-12-2796 · doi-reference
Metal-coordinated his-tag functionalization of polymeric nanogels for therapeutic applications
10.1021/acsanm.5c05531 · doi-reference
Water-nucleobase “Stacking”: H-π and lone Pair-π interactions in the atomic resolution crystal structure of an RNA pseudoknot
10.1021/ja0357801 · doi-reference
Photodynamic, UV-curable and fibre-forming polyvinyl alcohol derivative with broad processability and staining-free antibacterial capability
10.1016/j.eurpolymj.2025.113794 · doi-reference
Hyaluronic acid-polyethyleneimine nanogels for controlled drug delivery in cancer treatment
10.1021/acsanm.2c00524 · doi-reference
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
10.1016/j.bbcan.2023.189052 · doi-reference
Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix Metalloproteinase-2
10.1074/jbc.m107571200 · doi-reference
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
10.1158/1541-7786.mcr-23-0347 · doi-reference
Novel insights into the role of discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention
10.1016/j.matbio.2023.12.003 · doi-reference
Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
10.1073/pnas.1805020115 · doi-reference
Folate-decorated nanogels for targeted therapy of ovarian cancer
10.1016/j.biomaterials.2011.04.006 · doi-reference
A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells
10.1038/s42003-022-03966-w · doi-reference
Synthesis and biomedical applications of fluorescent nanogels
10.1039/c6py01021k · doi-reference
Selective modulation of A1 astrocytes by drug-loaded nano-structured gel in spinal cord injury
10.1021/acsnano.9b05579 · doi-reference
Effects of primary amine-based coatings on microglia internalization of nanogels
10.1016/j.colsurfb.2019.110574 · doi-reference
Nanogels as nanocarriers for drug delivery: a review
10.5599/admet.724 · doi-reference
Smart stimuli-responsive nanogels: a potential tool for targeted drug delivery
10.2174/0113816128353985241231111149 · doi-reference
Synthesis of novel N-Vinylpyrrolidone/Acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells
10.1016/j.colsurfb.2019.110566 · doi-reference
Design and development of polymeric micelles with cleavable links for intracellular drug delivery
10.1016/j.progpolymsci.2012.07.002 · doi-reference
Modulation of electrostatic interactions to improve controlled drug delivery from nanogels
10.1016/j.msec.2016.11.081 · doi-reference
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance
10.1038/s41568-024-00723-5 · doi-reference
The development of avastin
10.1007/978-3-540-33177-3_35 · doi-reference
Integrin signaling in cancer cell survival and chemoresistance
10.1155/2012/283181 · doi-reference
Beyond matrix stiffness: targeting force-induced cancer drug resistance
10.1016/j.trecan.2023.07.006 · doi-reference
Nanotechnology in cancer drug delivery and selective targeting
10.1155/2014/939378 · doi-reference
Drug delivery systems for overcoming physical barriers in cancer therapy
10.1021/acs.molpharmaceut.5c00474 · doi-reference
Nanomedicine disrupts stromal barriers to augment drug penetration for improved cancer therapy
10.1002/cjoc.202300642 · doi-reference